Seven Arrested in Federal Conspiracy Involving Annandale Doctor and Prescription Drug Distribution
Federal authorities announced the arrest of seven individuals from Maryland this week, following a federal grand jury indictment that charges them with conspiring to distribute large quantities of oxycodone pills and prescription cough syrup containing hydrocodone and codeine. The case centers on an Annandale, Virginia-based doctor who was already convicted in connection with the distribution of thousands of opioid pills and gallons of liquid narcotics. The charges, unsealed in the Western District of Virginia, outline a scheme in which the defendants allegedly used fraudulent patient identities to obtain controlled substances for illegal distribution across multiple states.
Source note: This article is based on a public release from the Federal Bureau of Investigation.
The Federal Indictment and the Defendants
A federal grand jury sitting in Abingdon, Virginia returned the indictment on August 26, 2025, but the arrests were carried out this week, according to the FBI. The seven defendants, all from Maryland, range in age from 23 to 31. They are: Obioma Alozie Ndubuka, also known as “Bankroll,” 31, of Gaithersburg; Raymono Alfonzo Russell II, 24, of Bowie; Cameron Isaiah Lewis, 23, of Bowie; Elhadj Malick Diallo, 31, of Silver Spring; Zion Oluwademilade Adeduwon, 24, of Bowie; Kenechukwu Brian Okwara, also known as “Kene,” 29, of Bowie; and Yared Michael Tesfaye, also known as “Yar,” 28, of Montgomery Village.
The indictment charges each defendant with one count of conspiracy to distribute and possess with intent to distribute oxycodone and hydrocodone-chlorpheniramine solution, two counts of possessing with intent to distribute hydrocodone-chlorpheniramine solution, and four counts of obtaining drugs by fraud. The conspiracy charge alone carries significant potential penalties, though specific sentencing ranges depend on many factors and are not provided in the initial release.
The Alleged Conspiracy: How the Scheme Worked According to Prosecutors
According to court documents cited by the FBI, the conspiracy operated in at least 2023 and 2024. The indictment names Rotimi Iluyomade as a central figure—the Annandale-based doctor who has already been convicted for illegally distributing more than 7,000 oxycodone pills, 34,000 milliliters of hydrocodone-chlorpheniramine solution (sold under the brand name Tussionex), and 107,000 milliliters of promethazine-codeine solution. Iluyomade’s prior conviction was not elaborated upon in the new release, but it forms a backdrop for the current charges.
The seven newly arrested defendants allegedly entered into an agreement with Iluyomade and other unnamed co-conspirators to distribute oxycodone pills and Tussionex to individuals in multiple states, as well as to acquire promethazine-codeine solution by fraud. The indictment claims that multiple co-conspirators visited Iluyomade’s medical clinic to obtain fraudulent prescriptions for these controlled substances.
A key part of the scheme involved providing Iluyomade with lists of so-called “patients.” These lists contained fake identifying information, variations of names, and false addresses. The doctor then allegedly wrote prescriptions for these non-existent patients, and the prescriptions were transmitted to pharmacies across the United States. At least 70 of the illegal prescriptions were sent to or filled at pharmacies in the Western District of Virginia, which is why the case is being prosecuted there.
The alleged fraud also involved multiple pharmacies. The defendants are accused of causing the prescriptions to be sent to pharmacies in several states, then having the drugs dispensed and diverted for illegal distribution. The specific drugs include oxycodone, a powerful opioid painkiller, and two types of codeine-containing cough syrups—promethazine-codeine, often associated with recreational use and abuse, and hydrocodone-chlorpheniramine, another combination narcotic cough suppressant.
The Geographic and Organizational Scope
The indictment paints a picture of a drug trafficking organization that operated across state borders. While the doctor’s clinic was in Annandale, Virginia, and the defendants resided primarily in Bowie and other Maryland suburbs, the alleged scheme reached pharmacies across the country. The fact that at least 70 illegal prescriptions were filled in the Western District of Virginia, a region not immediately adjacent to the Washington, D.C., area, suggests that the conspirators intentionally sought out pharmacies in multiple locations to avoid detection. This modus operandi is not unusual in prescription fraud cases, where diverters may target pharmacies in rural or less-monitored areas.
The involvement of Nebraska State Police also signals that the investigation extended well beyond the Mid-Atlantic. While the specific Nebraska connection was not detailed, it may indicate that fraudulent prescriptions were sent to pharmacies there, or that some of the drugs were distributed in that state. The multi-state nature of the conspiracy is one reason federal charges were brought, as federal prosecutors have jurisdiction over crimes that cross state lines.
The Role of the Annandale-Based Doctor
Rotimi Iluyomade’s conviction was not detailed in the new announcement, but the charges against the seven defendants are built, in part, on his prior actions. The FBI release notes his conviction for distributing massive amounts of controlled substances, and the new indictment references the period of at least 2023 and 2024, suggesting an ongoing pattern. The fact that a medical professional was central to the operation highlights concerns about prescription drug diversion and the responsibilities of healthcare providers in preventing such fraud.
The case does not provide a complete biography of Iluyomade; it is focused on the conduct alleged. However, the use of his clinic as a venue for fraudulent prescriptions points to a vulnerability in the prescription drug monitoring system that investigators and prosecutors take seriously. The involvement of multiple law enforcement agencies, including the DEA and FDA, indicates a broad investigation into pharmaceutical crimes.
Controlled Substances Involved: Oxycodone and Promethazine-Codeine
Oxycodone is a potent semi-synthetic opioid prescribed for moderate to severe pain. Illegally, it is often abused for its euphoric effects and can lead to addiction, overdose, and death. The indictment alleges distribution of more than 7,000 pills—a quantity that, if confirmed, suggests a significant black market operation. The source does not provide information about the specific dosage strengths or the street value of the pills, but federal law treats such quantities seriously.
Promethazine-codeine solution is a prescription cough syrup that combines an antihistamine with codeine, an opioid. It is sometimes abused recreationally, often mixed with soft drinks or alcohol, and is known by names such as “lean” or “purple drank.” The diversion of such syrups has been a concern among law enforcement for years. The indictment alleges that the conspirators obtained promethazine-codeine by fraud, meaning they used fraudulent prescriptions to acquire it from pharmacies with the intent to sell or distribute it illegally.
Hydrocodone-chlorpheniramine solution, or Tussionex, is another combination narcotic cough medicine. This is a Schedule II controlled substance due to its high potential for abuse. The alleged distribution of over 34,000 milliliters of this solution represents a large volume, further indicating the scale of the operation.
The Multi-Agency Investigation
The investigation involved a coalition of federal, state, and local agencies. The Drug Enforcement Administration (DEA) and the FBI led the federal effort, with support from the Virginia State Police, the Salisbury (Maryland) Police Department, the Loudoun County Sheriff’s Office, the Russell County Sheriff’s Office, Nebraska State Police, the HHS Office of Inspector General, and the Food and Drug Administration. This extensive coordination suggests a case that crossed state lines and required multiple jurisdictions to build the indictment.
Additional assistance came from the U.S. Attorney’s Office for the District of Maryland, Greenbelt Division, and the Maryland Department of Public Safety and Correctional Services. The involvement of these offices underscores the regional nature of the alleged conspiracy, which touched Maryland, Virginia, and other states.
The prosecution is being handled by Assistant U.S. Attorneys Lena Busscher and Randy Ramseyer in the Western District of Virginia. The announcement was made by Acting United States Attorney Robert N. Tracci and Special Agent in Charge Reid Davis of the FBI Washington Field Office’s Criminal Division.
What the Charges Mean and the Legal Process Ahead
An indictment is a formal accusation, not a finding of guilt. All seven defendants are presumed innocent unless and until prosecutors prove the charges beyond a reasonable doubt in a court of law. The charges include a conspiracy count, which often allows prosecutors to introduce evidence of a larger scheme, and multiple specific counts of drug possession with intent to distribute and fraud.
The conspiracy charge focuses on the agreement to commit the crimes and at least one overt act in furtherance of that agreement. According to the indictment, the agreement involved distributing oxycodone and Tussionex, and obtaining promethazine-codeine by fraud. The two possession with intent counts and the four fraud counts relate to specific instances. The exact penalties depend on the drug quantities and other factors, such as the defendants’ criminal histories, and will be determined by a judge if they are convicted.
Following the arrests this week, the defendants will appear before a federal magistrate judge for initial hearings, where they will be formally notified of the charges and have the opportunity to enter a plea. At this stage, it is common for defendants to be detained pending further proceedings, or to be released on bond with conditions. The case will then move through the pre-trial process, which may involve discovery, motion practice, and possibly plea negotiations. A trial date would be set if the case is not resolved otherwise.
Public-Interest Context: Why This Case Matters
Federal prosecutions of prescription drug trafficking are part of a broader effort to combat the opioid crisis. While the source does not provide epidemiological data, the diversion of prescription opioids and codeine-based cough syrups contributes to addiction and overdose-related public safety concerns. Cases involving medical professionals who abuse their prescribing authority can undermine public trust in the healthcare system.
The cooperation among multiple agencies also demonstrates the importance of interagency and interstate collaboration in modern drug enforcement. The investigation involved local police, state police, and federal agencies, highlighting the complexity of such cases. The fact that the alleged scheme used fraudulent patient lists and crossed many state lines underscores the challenges in monitoring prescription drug diversion, but also the ability of law enforcement to track these patterns.
For readers in Maryland, Virginia, and beyond, this case serves as a reminder that prescription drug fraud and trafficking are not victimless crimes. They can fuel addiction, fund further criminal activity, and compromise the integrity of the medical system. While the details of this specific case are still unfolding, the charges indicate a serious effort by authorities to intervene.
What Remains Unclear
Several aspects of the case are not yet public. The FBI release does not detail the specific roles of each defendant, the exact amounts of drugs each allegedly distributed or possessed, or the total financial gains. It also does not explain how the investigation began, what evidence was gathered beyond the prescriptions themselves, or whether any of the defendants have prior criminal records. The release states that the investigation is ongoing, which may mean additional defendants or charges could follow.
The connection between the earlier conviction of Rotimi Iluyomade and this new case is not fully explained. It is unclear whether the conduct in this indictment overlaps with the earlier case or is a separate conspiracy. The identity of the unnamed co-conspirators and any potential pharmacies that may have been involved are also not disclosed. The public will learn more as the case proceeds in court, when government filings and possible hearings fill in these gaps.
Frequently Asked Questions
What did authorities say happened?
According to the FBI, a federal grand jury indicted seven people for conspiring with a doctor to distribute oxycodone and codeine-based cough syrup. The indictment alleges they provided fraudulent patient information to the doctor to obtain prescriptions, which were then filled at pharmacies across multiple states and the drugs distributed illegally.
Who was arrested and what are the charges?
Seven Maryland men were arrested: Obioma Ndubuka, Raymono Russell, Cameron Lewis, Elhadj Diallo, Zion Adeduwon, Kenechukwu Okwara, and Yared Tesfaye. They face charges of conspiracy to distribute oxycodone and hydrocodone-chlorpheniramine, possession with intent to distribute hydrocodone-chlorpheniramine, and obtaining drugs by fraud. The doctor involved, Rotimi Iluyomade, had already been convicted in a related case.
What substances were involved?
The case alleges distribution of more than 7,000 oxycodone pills, 34,000 milliliters of Tussionex (hydrocodone-chlorpheniramine), and obtaining promethazine-codeine solution by fraud. These are all controlled substances with high potential for abuse.
What happens next in the case?
The defendants will appear in federal court for initial hearings. They are presumed innocent until proven guilty. The case will proceed through pre-trial motions and possibly trial. No trial date has been set as of the announcement.
Why does this case matter?
It highlights the problem of prescription drug diversion, where fraudulent prescriptions are used to obtain opioids and narcotic cough syrups for illegal sale. The involvement of a medical professional makes it a serious breach of trust, and the multi-agency investigation shows the extensive resources applied to such cases.
Sources
This article is based on public information released by the Federal Bureau of Investigation and has been independently rewritten, summarized, and contextualized by Shadab Chow News. It is not affiliated with or endorsed by the FBI, the Department of Justice, any court, or any government agency. It may be updated as more confirmed information becomes available.